Incyte chief discusses company's latest cancer treatments, effects of U.S. tax cuts
Share

Incyte chief discusses company's latest cancer treatments, effects of U.S. tax cuts

The full interview with Incyte CEO Herve Hoppenot at J.P. Morgan Health in San Francisco.
05:00
Mon, Jan 8 20182:30 PM EST